Sublingual minoxidil: how under-the-tongue minoxidil compares with tablets and lotion, and what the trials show
What sublingual minoxidil is, why dissolving it under the tongue may change how the body handles it, what the trials from 2020 to 2026 found against placebo and swallowed tablets, the side effects, and what to ask a doctor in Malaysia.
If you have spent any time reading about hair loss online, you may have seen people talk about putting a tiny minoxidil tablet under the tongue instead of swallowing it. The idea sounds clever. The medicine melts into the mouth, skips the first trip through the liver and, the theory goes, reaches the hair follicles with fewer effects on blood pressure and heart rate. A handful of small trials from Australia and Brazil have now tested this, and a randomised trial published in 2026 added new data.
This guide explains what sublingual minoxidil is, how it is meant to differ from minoxidil lotion and low-dose minoxidil tablets, what each trial actually found, where the evidence is still weak, and what someone in Malaysia should think about before asking a doctor about it. It is general information, not personal medical advice. For background, see minoxidil in Malaysia, oral minoxidil and extended-release minoxidil pills.
The short answer
Sublingual minoxidil means a low dose of minoxidil, usually in a small tablet, that dissolves under the tongue. Because it is absorbed through the lining of the mouth, it partly avoids first-pass processing in the liver 1. Small trials suggest it can increase hair counts in male and female pattern hair loss, with benefit that seems to rise with dose 1 2. In a 110 man trial, 5 mg under the tongue worked about as well as 5 mg swallowed, with fewer reports of palpitations 3. A 2026 placebo-controlled trial in trans people on testosterone also found higher frontal hair counts at 24 weeks 4. The evidence is still early, the trials are small, several involve researchers with patents on the method, and sublingual minoxidil is not a standard approved product. It is a prescription decision to discuss with a doctor, not something to try with tablets bought online.
Why minoxidil comes in different forms
Minoxidil started life as a blood pressure tablet. Doctors noticed that patients grew extra hair, and that observation led to the minoxidil lotion and foam that people now apply to the scalp 5 6. In recent years, dermatologists have also prescribed very low doses of the tablet for hair loss, an approach usually called low-dose oral minoxidil 6 7.
Each form is a different trade-off.
- Topical minoxidil acts mainly where it is applied. Only a small share is absorbed into the body, which keeps whole-body effects low, but it has to be applied every day, it can irritate the scalp, and the solution form often contains alcohol and propylene glycol 8 4.
- Low-dose oral minoxidil is simple to take and treats the whole scalp at once. Because it enters the bloodstream, it carries a small risk of effects such as dizziness, fluid retention and a faster heart rate, and it commonly causes extra hair on the face and body 9.
- Sublingual minoxidil is an attempt to keep the convenience of a tablet while reducing some of the blood pressure and heart effects.
How minoxidil works in the follicle
To understand why the route matters, it helps to know what minoxidil does to a hair follicle.
Each scalp hair grows in a cycle. A long growth phase called anagen can last years. A short transition called catagen follows, then a resting phase called telogen, after which the old hair sheds and a new one starts. In pattern hair loss, the hormone DHT acts on genetically sensitive follicles and gradually shrinks them. This is called miniaturisation. With each cycle the hair becomes shorter and finer, until some follicles make only soft, almost invisible fuzz 10 11. See DHT and hair loss for the hormone side.
Minoxidil does not block DHT. It works on the growth side of the cycle, encouraging follicles to enter anagen sooner, stay in it longer and produce thicker hairs 6.
The key detail is that minoxidil is a prodrug. It has to be converted into its active form, minoxidil sulfate, by enzymes called sulfotransferases. In the follicle, an enzyme called SULT1A1 does this work, and its activity varies a lot between people, which is one reason some people respond poorly to minoxidil lotion 12. When minoxidil is swallowed, a large share of it passes first through the liver, where it is also converted. The active form circulating in the blood is linked to the blood pressure effects, such as a drop in pressure on standing and a faster pulse 4.
What makes sublingual different
A tablet placed under the tongue dissolves, and the medicine is absorbed through the thin lining of the mouth straight into the bloodstream. It avoids that first pass through the liver 1. The theory behind sublingual minoxidil has two parts.
- Less is converted in the liver straight away, so the level of the active form that drives blood pressure effects may rise more gently 1 4.
- More unchanged minoxidil may reach the follicles, where the follicle's own enzymes can convert it locally 1 4.
In the first phase 1B trial, the average peak blood level after a 0.45 mg sublingual dose was 1.62 ng/mL at 30 minutes, and minoxidil was no longer detectable after 24 hours. The authors noted this is far below the level linked to blood pressure effects, and they found no significant change in blood pressure 1. That is encouraging, but it came from a small group taking a very low dose.
What the trials found
The 64 patient case series (2020)
The first published experience came from an Australian dermatology practice that reviewed 64 people, 33 men and 31 women, treated with 0.45 mg sublingual minoxidil daily for more than six months, with the dose raised to 0.9 mg in some 13. Hair loss severity improved over 12 months. The most common side effect was mild extra hair growth in 12.5%, followed by mild dizziness on standing in 7.8% and mild ankle swelling in 3.1%, with no serious side effects recorded 13. This was a look back at records without a comparison group, so it can only suggest that the approach deserved proper testing.
The phase 1B placebo-controlled trial (2021)
Forty men and women aged 30 to 65 with moderate pattern hair loss took either 0.45 mg sublingual minoxidil or a placebo every day for 24 weeks 1. On close-up hair counts, the 0.45 mg dose added on average 4 terminal hairs per square centimetre at the front and 9 at the crown. The frontal result was statistically significant compared with placebo; the crown result was not. Twelve people then entered an open extension on higher doses. Average gains were 10 and 26 hairs per square centimetre at the front and crown with 1.35 mg, and 38 and 88 with 4.05 mg 1. The extension had very few people and no placebo group running at the same time, so those larger numbers need caution.
Hair thickness (2025)
A follow-up analysis of 33 men from that trial tracked individual hairs to see whether they became thicker. Over 24 weeks, hairs became 2 micrometres thinner on average with placebo and with 0.45 mg. With 1.35 mg they became 3 micrometres thicker, and with 4.05 mg, 6 micrometres thicker 2. Thicker shafts are a sign that shrunken follicles are recovering size, which is the reverse of miniaturisation. The authors declared that the lead researcher holds patents on oral and sublingual minoxidil for hair loss, which is worth knowing when reading the results 2.
Sublingual versus swallowed, head to head (2024)
This is the most useful trial for a practical decision. In Brazil, 110 men with crown-pattern hair loss were randomised to 5 mg sublingual minoxidil or 5 mg swallowed minoxidil daily for 24 weeks, each with a matching placebo so nobody knew which they had 3. Eighty-five finished. Total hair density at the crown rose by 24.5 hairs per square centimetre with sublingual and 21.8 with swallowed minoxidil, a difference that was not statistically significant. Blinded dermatologists judged that 42% and 40% improved. Extra hair growth was the main side effect. Palpitations were reported by 0% in the sublingual group and 9% in the swallowed group 3. The authors pointed out that blood pressure and heart rate were not measured, it was a single centre, and the sample was small 3.
Trans people on testosterone (2026)
A randomised, double-blind trial published in 2026 tested sublingual minoxidil in 46 trans people recorded female at birth who were taking testosterone and had mild pattern hair loss 4. Finasteride type medicines can interfere with the intended effects of testosterone, so a non-hormonal option matters for this group. Participants took 1.35 mg twice daily or placebo for 24 weeks. Hair counts at the front rose by 15.7 hairs per square centimetre more than placebo, but there was no difference at the crown at 24 weeks. In a later open phase on 2.5 mg twice daily, crown hair counts did improve by week 48 compared with the start. Testosterone levels were unaffected and there were no serious side effects. Blinded dermatologists, however, could not see a difference in standard photographs 4. That gap between hair counts and what the eye sees is common in hair research and is a good reminder to keep expectations modest.
Comparison of minoxidil forms
| Form | How it is taken | Where most conversion happens | Evidence for hair loss | Common concerns |
|---|---|---|---|---|
| Topical lotion or foam | Applied to the scalp once or twice a day | In the follicle | Large trials over decades | Scalp irritation, daily effort, early shedding |
| Low-dose oral tablet | Swallowed daily, prescribed off-label | Liver and follicle | Growing trials and large safety reviews | Extra body and facial hair, dizziness, swelling, faster pulse |
| Sublingual tablet | Dissolved under the tongue | Partly avoids the liver at first | A few small trials, mostly from one research group | Same as oral, possibly fewer palpitations; not a standard product |
| Extended-release tablet | Swallowed, releases slowly | Liver and follicle | Phase 3 trials, not yet approved | Still under regulatory review |
Sources for the table: 6 9 3 1. For the extended-release approach, see VDPHL01.
Side effects and who should be careful
Sublingual minoxidil is the same medicine as the tablet, so the same cautions apply. In a large review of 1,404 people taking low-dose oral minoxidil for hair loss, the most common effect was extra hair growth on the face or body (15.1%). Lightheadedness (1.7%), fluid retention (1.3%) and a fast heartbeat (0.9%) were less common, and 1.7% stopped because of side effects 9. The sublingual trials reported a similar pattern, mainly extra hair, with some dizziness and swelling 13 3.
The 2026 trial excluded people who were pregnant or breastfeeding, and people with heart failure, pulmonary hypertension, cerebrovascular disease or a rare adrenal tumour called pheochromocytoma 4. Anyone with heart disease, low or poorly controlled blood pressure, kidney problems, or who takes blood pressure medicines should only consider minoxidil tablets after a careful medical review. A shared consensus of hair experts has also set out screening and starting doses for low-dose oral minoxidil 7.
Shedding in the first weeks can happen with any form of minoxidil as follicles move into a new cycle. See minoxidil shedding. Extra facial hair is a particular concern for many women, and is covered in oral minoxidil for women.
What to expect, step by step
- Diagnosis first. Minoxidil helps pattern hair loss. It is less useful if shedding is caused by thyroid problems, iron deficiency, a recent illness or alopecia areata. A doctor will look at the pattern, check the scalp and may suggest blood tests. See telogen effluvium vs pattern hair loss.
- A medical review. Blood pressure, pulse, medical history and current medicines are checked, because tablets act on the whole body 7.
- A low starting dose. In the trials, doses started very low, from 0.45 mg, and were raised slowly 1 4.
- Weeks 2 to 8. Some people notice shedding as old resting hairs are pushed out. Watch for dizziness on standing, ankle swelling or a racing heart, and report them.
- Months 3 to 6. Early changes may appear, usually as finer hairs becoming slightly thicker. Trials typically judge results at 24 weeks 1 3.
- Months 6 to 12. A fair point to review progress using photos taken under the same light. See tracking hair loss with photos and how long minoxidil takes.
- Long term. Like all forms of minoxidil, benefit lasts only while it is used. Stopping usually leads to the gained hair being lost over the following months 6.
Malaysian context
In Malaysia, minoxidil tablets are a prescription medicine, and their use for hair loss is off-label, so any tablet based approach, swallowed or sublingual, belongs under a doctor's care 6. The trials used carefully dosed study tablets, and a standard sublingual minoxidil product is not widely available. Be wary of online sellers offering "hair loss tablets" or tiny dose pills without a prescription. You can check whether a medicine is registered on the NPRA QUEST product search 14, and checking hair products with NPRA explains how.
The climate matters too. In hot, humid weather, people sweat more and may drink less than they should. Dizziness on standing can feel worse when you are dehydrated, so stand up slowly, keep water at hand, and tell your doctor if you feel faint. A foam, a once daily routine or a consultation about other options may also help. See minoxidil foam vs solution.
Some Muslim patients also ask about alcohol in topical minoxidil. A tablet avoids the alcohol based liquid used in many solutions 8, although tablet ingredients still vary. See is minoxidil halal for a fuller discussion. Costs differ widely between providers and no verified price source exists for sublingual minoxidil in Malaysia, so ask for a written quote that includes consultations and follow-up checks.
For a scalp assessment and a plan, consider a dermatologist or an experienced hair care centre, for example in Kuala Lumpur, Penang or Sibu. See hair loss treatment in KL, Penang and Sibu.
Pros and cons
Possible advantages
- Convenient, with no daily scalp application and no sticky residue in the heat.
- In one head to head trial, fewer palpitations than swallowing the same dose, with similar hair results 3.
- A non-hormonal option for people who cannot or do not want to use finasteride type medicines 4.
Limitations and risks
- Small trials, short follow-up and limited independent replication 1 3.
- Several studies involve researchers with commercial interests in the method 2.
- Same whole-body side effects as oral minoxidil, especially extra facial and body hair 9.
- Not a standard approved product, and still needs a prescription and monitoring.
- It does not block DHT, so men with progressing loss may still need a DHT-focused treatment discussed with a doctor. See minoxidil and finasteride together.
Common myths
- "Sublingual is stronger than oral." Not proven. In the head to head trial, results were similar at the same dose 3.
- "It has no side effects." It is the same medicine. Extra hair, dizziness and swelling can still occur 13.
- "You can cut a blood pressure tablet and put it under your tongue." Doses in the trials were small and carefully prepared. Cutting tablets at home is imprecise and unsafe without medical advice.
- "If it works, you can stop later and keep the hair." Benefit fades after stopping, as with every form of minoxidil 6. See stopping minoxidil.
Practical checklist before you ask about sublingual minoxidil
- Have your hair loss diagnosed, ideally with a scalp examination.
- Write down your medicines, supplements and any heart, blood pressure or kidney history.
- Tell your doctor if you are pregnant, planning a pregnancy or breastfeeding.
- Ask whether topical minoxidil, a tablet, or a combination fits your situation better.
- Ask what dose would be used, how it is prepared, and how blood pressure and pulse will be checked.
- Take baseline photos in the same light and plan to review at six and twelve months.
- Never buy minoxidil tablets online without a prescription, and check registration on NPRA QUEST 14.
Summary
Sublingual minoxidil is a promising variation on an old medicine. The idea, absorbing minoxidil through the mouth so less is converted in the liver at first, makes sense on paper, and small trials show increases in hair counts and hair thickness, with similar results to swallowed minoxidil and fewer palpitations in one head to head study 1 2 3. The 2026 trial in people on testosterone adds placebo-controlled evidence for a group with few other options 4. Even so, the studies are small and early, and the side effects are those of minoxidil tablets. For most people in Malaysia, the sensible route is a proper diagnosis, then a conversation with a doctor about whether topical, oral or sublingual minoxidil suits them. Results vary from person to person.
Frequently asked questions
What is sublingual minoxidil?
It is low-dose minoxidil, usually a small tablet, dissolved under the tongue. It is absorbed through the lining of the mouth and partly avoids first-pass processing in the liver 1.
Is sublingual minoxidil better than oral minoxidil?
Not proven. In a trial of 110 men, 5 mg under the tongue and 5 mg swallowed gave similar hair results, with fewer palpitations in the sublingual group 3.
Does sublingual minoxidil work for women?
The early trial and case series included women with pattern hair loss and reported benefit, but numbers were small. Extra facial hair is a common concern 1 13.
What are the side effects?
Mostly extra hair on the face or body. Dizziness on standing, ankle swelling and a fast heartbeat are less common, as with low-dose oral minoxidil 13 9.
How long before I see results?
Trials judged results at about 24 weeks, and some changes kept building to 48 weeks. Give it six to twelve months before deciding 1 4.
Can I get sublingual minoxidil in Malaysia?
Minoxidil tablets are prescription medicines in Malaysia and use for hair loss is off-label. Ask a doctor, and do not buy tablets online without a prescription 6 14.
Will my hair fall again if I stop?
Usually yes. As with every form of minoxidil, the benefit lasts only while it is used 6.
Sources
- PubMed (Bokhari, Jones & Sinclair, J Eur Acad Dermatol Venereol, 2022). Sublingual minoxidil for the treatment of male and female pattern hair loss: a randomized, double-blind, placebo-controlled, phase 1B clinical trial, 2022. accessed 27 Oct 2026
- PubMed (Sinclair et al., Clin Exp Dermatol, 2025). Sublingual minoxidil increases fibre diameter in male androgenetic alopecia: a proxy for reversal of hair follicle miniaturization, 2025. accessed 27 Oct 2026
- PubMed (Sanabria et al., J Eur Acad Dermatol Venereol, 2025). Sublingual minoxidil 5 mg versus oral minoxidil 5 mg for male androgenetic alopecia: a double-blind randomized clinical trial, 2025. accessed 27 Oct 2026
- PubMed (Tang et al., J Am Acad Dermatol, 2026). Treatment of androgenetic alopecia in transgender people receiving testosterone therapy with sublingual minoxidil: a randomized, double-blind, placebo-controlled clinical trial, 2026. accessed 27 Oct 2026
- MedlinePlus (US National Library of Medicine). Minoxidil topical. accessed 27 Oct 2026
- PubMed. Oral minoxidil treatment for hair loss: A review of efficacy and safety, J Am Acad Dermatol, 2021. accessed 27 Oct 2026
- PubMed. Low-Dose Oral Minoxidil Initiation for Patients With Hair Loss: An International Modified Delphi Consensus Statement, JAMA Dermatol, 2025. accessed 27 Oct 2026
- DailyMed, US National Library of Medicine. Minoxidil Topical Solution USP, 5% (drug facts label: alcohol 28.86% v/v, propylene glycol, purified water), accessed 3 Nov 2026. accessed 27 Oct 2026
- PubMed. Safety of low-dose oral minoxidil for hair loss: A multicenter study of 1404 patients, J Am Acad Dermatol, 2021. accessed 27 Oct 2026
- DermNet. Male pattern hair loss. accessed 27 Oct 2026
- DermNet. Female pattern hair loss. accessed 27 Oct 2026
- PubMed (review, 2022). Sulfotransferase SULT1A1 activity in hair follicle, a prognostic marker of response to the minoxidil treatment in patients with androgenetic alopecia: a review, 2022. accessed 27 Oct 2026
- PubMed (Sinclair et al., J Eur Acad Dermatol Venereol, 2020). Treatment of male and female pattern hair loss with sublingual minoxidil: a retrospective case-series of 64 patients, 2020. accessed 27 Oct 2026
- National Pharmaceutical Regulatory Agency (NPRA), Malaysia. QUEST 3+ Product Search. accessed 27 Oct 2026
Educational content. Not medical advice.